MMA
DGX icon

Miracle Mile Advisors’s Quest Diagnostics DGX Stock Holding History

Miracle Mile Advisors’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$579K Sell
2,730
-9
-0.3% -$1.77K 0.01% 579
2026
Q1 		$537K Buy
2,739
+3
+0.1% +$583 0.01% 561
2025
Q4 		$475K Sell
2,736
-52
-2% -$9.47K 0.01% 583
2025
Q3 		$531K Buy
2,788
+70
+3% +$12.4K 0.01% 539
2025
Q2 		$488K Buy
2,718
+759
+39% +$132K 0.01% 488
2025
Q1 		$331K Buy
1,959
+31
+2% +$5.09K 0.01% 509
2024
Q4 		$291K Buy
+1,928
New +$300K 0.01% 527
2023
Q4 		– Sell
-2,181
Closed -$266K – 501
2023
Q3 		$266K Buy
2,181
+3
+0.1% +$400 0.01% 413
2023
Q2 		$306K Sell
2,178
-998
-31% -$138K 0.01% 418
2023
Q1 		$449K Buy
3,176
+128
+4% +$18.3K 0.01% 370
2022
Q4 		$477K Sell
3,048
-119
-4% -$17.1K 0.02% 361
2022
Q3 		$389K Sell
3,167
-286
-8% -$37.7K 0.02% 324
2022
Q2 		$459K Sell
3,453
-243
-7% -$33.1K 0.02% 307
2022
Q1 		$506K Sell
3,696
-17,915
-83% -$2.5M 0.02% 321
2021
Q4 		$3.74M Buy
21,611
+1,230
+6% +$187K 0.15% 128
2021
Q3 		$2.96M Buy
20,381
+973
+5% +$142K 0.14% 132
2021
Q2 		$2.56M Buy
19,408
+1,035
+6% +$136K 0.14% 130
2021
Q1 		$2.36M Buy
18,373
+396
+2% +$48.8K 0.13% 136
2020
Q4 		$2.14M Buy
17,977
+363
+2% +$44.3K 0.13% 138
2020
Q3 		$2.02M Buy
17,614
+503
+3% +$59.4K 0.14% 132
2020
Q2 		$1.95M Buy
17,111
+573
+3% +$60.8K 0.16% 129
2020
Q1 		$1.33M Sell
16,538
-207
-1% -$21.4K 0.14% 116
2019
Q4 		$1.79M Buy
16,745
+1,493
+10% +$156K 0.12% 122
2019
Q3 		$1.63M Sell
15,252
-408
-3% -$41.9K 0.11% 137
2019
Q2 		$1.59M Buy
15,660
+1,523
+11% +$146K 0.12% 133
2019
Q1 		$1.27M Buy
+14,137
New +$1.23M 0.1% 143

Other funds holding DGX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

Miracle Mile Advisors's DGX Position: Q2 2026 in Review

Miracle Mile Advisors reduced its Quest Diagnostics (DGX) stake by 0.33% in Q2 2026, selling an estimated $1.77K and leaving 2,730 shares worth $579K. The position accounts for 0.01% of the portfolio, ranked #579.

Miracle Mile Advisors first reported a position in DGX in Q1 2019 and has held it in 26 quarters since. The position peaked at $3.74M in Q4 2021. 1,100 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Miracle Mile Advisors held 2,730 shares of Quest Diagnostics worth $579K as of Q2 2026.
  • Miracle Mile Advisors sold 9 Quest Diagnostics shares in Q2 2026, an estimated $1.77K.
  • Quest Diagnostics made up 0.01% of Miracle Mile Advisors's portfolio in Q2 2026, its #579 holding.
  • Miracle Mile Advisors first reported a position in Quest Diagnostics in Q1 2019 and has held it in 26 quarters since.
  • Miracle Mile Advisors's Quest Diagnostics position peaked at $3.74M in Q4 2021.
  • 1,100 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Miracle Mile Advisors's 13F filing for Q2 2026, filed 22 Jul 2026.